(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Countdown to Earnings: Tesla, Abbott Laboratories, and IBM Take the Stage

  • January 21st, 2024
  • 257 views

On Wednesday, January 24, a lineup of major companies is set to reveal their financial performances:

Tesla, Inc. (Nasdaq: TSLA), the electric vehicle and clean energy company, will release its financial results for the fourth quarter of 2023 after the market's closing bell. 

Analysts are expecting an earnings per share (EPS) of $0.74 on revenue totaling $25.57 billion. 

$TSLA closed at $212.19 on Friday, marking a modest increase of $0.31 (0.15%).

Abbott Laboratories (NYSE: ABT), a global healthcare company, is scheduled to announce its fourth-quarter 2023 financial results before the market opens.

The consensus EPS estimate stands at $1.19, accompanied by revenue amounting to $10.18 billion. 

On Friday, $ABT closed at $114.69, reflecting a gain of $0.67 (0.59%).

International Business Machines Corporation (NYSE: IBM), a technology and consulting giant, will release its fourth-quarter 2023 earnings after the close of the market. 

Analysts forecast an EPS of $3.76 on revenue amounting to $17.23 billion.

$IBM closed at $171.48 on Friday, up $4.64 (2.78%)

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13